Novel Anxiolytic Compounds
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 8 of these applications claim priority to application PCT/AU2007/001566, filed Oct 16, 2007. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 8,551,990 | Novel Anxiolytic Compounds In force · Medium confidence | Bionomics Limited | In force | Medium confidence | ||
| US 8,614,212 | Novel Anxiolytic Compounds In force · Medium confidence | Bionomics Limited | In force | Medium confidence | ||
| US 8,906,912 | Novel Anxiolytic Compounds In force · Medium confidence | Bionomics Limited | In force | Medium confidence | ||
| US 9,573,945 | Novel Anxiolytic Compounds In force · High confidence | Bionomics Limited | In force | High confidence | ||
| US 9,975,892 | Novel Anxiolytic Compounds In force · Medium confidence | Bionomics Limited | In force | Medium confidence | ||
| US 10,233,181 | Novel Anxiolytic Compounds In force · Medium confidence | Bionomics Limited | In force | Medium confidence | ||
| US 10,954,231 | Novel Anxiolytic Compounds In force · High confidence | Bionomics Limited | In force | High confidence | ||
| US 8,293,737 | Novel Anxiolytic Compounds In force · High confidence | Bionomics Limited | In force | High confidence |
8 of 8 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.